Using Caenorhabditis elegans as a Model for Obesity Pharmacology Development.

about

A novel transdermal nanoethosomal gel of betahistine dihydrochloride for weight gain control: in-vitro and in-vivo characterization.Betahistine decreases olanzapine-induced weight gain and somnolence in humans.

P2860

Q46495793-8A626160-B2D1-4DF7-BC2D-3026C6738E31 Q47328428-C9AB2200-34B4-4051-A28F-B8FE90425F18

P2860

Using Caenorhabditis elegans as a Model for Obesity Pharmacology Development.

Item

http://www.wikidata.org/entity/Q47121505

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh-hant

name

Using Caenorhabditis elegans as a Model for Obesity Pharmacology Development.

@en

Using Caenorhabditis elegans as a Model for Obesity Pharmacology Development.

@nl

type

Item

label

Using Caenorhabditis elegans as a Model for Obesity Pharmacology Development.

@en

Using Caenorhabditis elegans as a Model for Obesity Pharmacology Development.

@nl

prefLabel

Using Caenorhabditis elegans as a Model for Obesity Pharmacology Development.

@en

Using Caenorhabditis elegans as a Model for Obesity Pharmacology Development.

@nl

P1476

Using Caenorhabditis elegans as a Model for Obesity Pharmacology Development.

@en

P2093

Frank L Greenway

http://www.w3.org/2001/XMLSchema#string

Frederic M Enright

http://www.w3.org/2001/XMLSchema#string

Jason F King

http://www.w3.org/2001/XMLSchema#string

John W Finley

http://www.w3.org/2001/XMLSchema#string

Jolene Zheng

http://www.w3.org/2001/XMLSchema#string

Joseph R Vasselli

http://www.w3.org/2001/XMLSchema#string

Michael J Keenan

http://www.w3.org/2001/XMLSchema#string

Michael L King

http://www.w3.org/2001/XMLSchema#string

Roy J Martin

http://www.w3.org/2001/XMLSchema#string

Wenqian We

http://www.w3.org/2001/XMLSchema#string

P2860

Genome sequence of the nematode C. elegans: a platform for investigating biology

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Moderate weight-lowering effect of octopamine treatment in obese Zucker rats

Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells

A comparative study of fat storage quantitation in nematode Caenorhabditis elegans using label and label-free methods

Rapid gene mapping in Caenorhabditis elegans using a high density polymorphism map

Insulin, cGMP, and TGF-beta signals regulate food intake and quiescence in C. elegans: a model for satiety

Betahistine increases vestibular blood flow.

High-throughput isolation of Caenorhabditis elegans deletion mutants

HIV-protease inhibitors suppress skeletal muscle fatty acid oxidation by reducing CD36 and CPT1 fatty acid transporters.

P304

e1363-e1370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MJT.0000000000000061

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

W D Johnson

P577

2014-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24786852

http://www.w3.org/2001/XMLSchema#string

P921

Adipositas

Farmakologi

Caenorhabditis elegans

P932

5751951

http://www.w3.org/2001/XMLSchema#string

Using Caenorhabditis elegans as a Model for Obesity Pharmacology Development.

about

P2860

P2860

Using Caenorhabditis elegans as a Model for Obesity Pharmacology Development.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932